| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.009 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |